Name: Artificial Heart Market Size, Competitive Landscape and Market Forecast - 2029
Brand: DataM Intelligence
SKU: DMMD1337
Price: 4350 USD
Availability: InStock

Artificial Heart Market Size Share Growth Opportunities and Forecast 2022

Artificial Heart Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global&nbsp;Artificial Heart Market is segmented By type of product (Ventricular Assist Device, Total Artificial Heart), By Application (Dilated Cardiomyopathy, Ischemic Cardiomyopathy, and others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Artificial Heart Market&quot;&nbsp;Expected&nbsp;is expected to grow at a&nbsp;<a href="https://www.datamintelligence.com/download-sample/artificial-heart-market">CAGR of 15.58%</a>&nbsp;during the forecasting period (2022-2029).
</blockquote>

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/heart-attack-diagnostics-market">Heart Attack Diagnostics Market</a>

<a href="https://www.datamintelligence.com/research-report/heart-defect-closure-devices-market">Heart Defect Closure Devices Market</a>

<a href="https://www.datamintelligence.com/research-report/pediatric-interventional-cardiology-market">Pediatric Interventional Cardiology Market</a>

<h3>&nbsp;</h3>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

1. Methodology and Scope

1.1. Research Methodology

1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Global Artificial HeartMarket Executive Summary

3.1. Market Snippet by type of product

3.2. Market Snippet by application

4. Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Rising number of cardiac disorders

4.1.1.2. Growing geriatric population

4.1.1.3. Rising global patient population with end-stage heart failure

4.1.1.4. Improvements in the functionality of these synthetic heart replacement

4.1.2. Restraints

4.1.2.1. limited durability and longevity of artificial hearts.

4.1.3. Impact Analysis

5. Industry Analysis

5.1. Porter&#39;s Five Forces Analysis

5.2. Supply Chain Analysis

5.3. Regulatory Analysis

5.4. Pricing Analysis

6. By type of product

6.1. Introduction

6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

6.3. Market Attractiveness Index, By type of product

6.3.1. Ventricular Assist Device (VAD)*

6.3.1.1. Introduction

6.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026

6.3.2. Total Artificial Heart (TAH)

7. By application

7.1. Introduction

7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By application

7.3. Market Attractiveness Index, By application

7.3.1. Dilated Cardiomyopathy *

7.3.1.1. Introduction

7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2019-2026

7.3.2. Ischemic Cardiomyopathy

7.3.3. Others

8. By Region

8.1. Introduction

8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

8.3. Market Attractiveness Index, By Region

8.4. North America

8.4.1. Introduction

8.4.2. Key Region-Specific Dynamics

8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.4.5.1. U.S.

8.4.5.2. Canada

8.4.5.3. Mexico

8.5. Europe

8.5.1. Introduction

8.5.2. Key Region-Specific Dynamics

8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.5.5.1. Germany

8.5.5.2. U.K.

8.5.5.3. France

8.5.5.4. Italy

8.5.5.5. Spain

8.5.5.6. Rest of Europe

8.6. South America

8.6.1. Introduction

8.6.2. Key Region-Specific Dynamics

8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.6.5.1. Brazil

8.6.5.2. Argentina

8.6.5.3. Rest of South America

8.7. Asia Pacific

8.7.1. Introduction

8.7.2. Key Region-Specific Dynamics

8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

8.7.5.1. China

8.7.5.2. India

8.7.5.3. Japan

8.7.5.4. Australia

8.7.5.5. Rest of Asia Pacific

8.8. Middle East and Africa

8.8.1. Introduction

8.8.2. Key Region-Specific Dynamics

8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By type of product

8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9. Global Market Competitive Landscape

9.1. Competitive Scenario

9.2. Comparative Product Portfolio Analysis

9.3. Market Positioning/Share Analysis

9.4. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. AbioMed *

10.1.1. Company Overview

10.1.2. Product Portfolio and Description

10.1.3. Key Highlights

10.1.4. Financial Overview

10.2. BiVACOR

10.3. SynCardia

10.4. Jarvik Heart, Inc.

10.5. CARMAT

10.6. Medtronic

10.7. ReliantHeart Inc.

10.8. SynCardia Systems LLC

10.9. Abott

10.10. Corwave

11. DataM Intelligence

11.1. Appendix

11.2. About Us and Services

11.3. Contact Us